Hypothesis

It's been shown that ER‑tethered BCL‑2 sequesters Beclin‑1, but in aged cells the complex persists not only because of elevated expression but also because stress‑induced kinases don't phosphorylate BCL‑2 at the JNK1 sites (T69, S70, S87). We propose that chronic ER oxidative stress promotes disulfide‑linked dimerization of BCL‑2, which sterically hinders JNK1 access and locks the anti‑apoptotic protein in a high‑affinity conformation for Beclin‑1. This redox‑based lock maintains autophagy suppression even when nutrient signals would normally trigger release, contributing to the accumulation of damaged proteins and organelles seen in aging.

Mechanistic Basis

• ER‑tethered BCL‑2 is necessary for Beclin‑1 sequestration ER‑tethered BCL‑2 blocks autophagy.
• JNK1 phosphorylation of BCL‑2 releases Beclin‑1 during starvation JNK1‑mediated BCL‑2 phosphorylation.
• Aged liver shows increased BCL‑2 mRNA and reduced autophagic flux BCL‑2 upregulation in aged liver.
• ER oxidative stress rises with age, favoring disulfide bond formation and altering kinase docking surfaces.

We hypothesize that age‑dependent ER oxidation converts monomeric BCL‑2 into a disulfide‑linked oligomer that masks the JNK1 phosphorylation loop. Consequently, even if JNK1 activity is present, it can't efficiently modify BCL‑2, and the BCL‑2/Beclin‑1 complex persists. This model extends the current view by adding a post‑tra

Presbyphonia involves concurrent extracellular matrix (ECM) remodeling in the vocal fold lamina propria and atrophy of the thyroarytenoid (TA) muscle, yet aged TA muscle retains more activated satellite cells than limb muscles while failing to regenerate effectively【2】【5】. This paradox suggests that satellite cell activation is uncoupled from downstream differentiation or fusion, a step that could be blocked by changes in the local microenvironment. Recent work highlights hyaluronan (HA) as a key lamina propria glycosaminoglycan whose size and organization shift with age, producing low‑molecular‑weight fragments that act as damage‑associated molecular patterns【1】. We hypothesize that age‑related accumulation of fragmented HA in the vocal fold lamina propria creates a chronic low‑grade inflammatory niche that impairs TA satellite cell differentiation through Toll‑like receptor 4 (TLR4)–mediated NF‑κB signaling, thereby decoupling satellite cell activation from functional regeneration.

Mechanistic rationale: Low‑molecular‑weight HA binds TLR4 on resident fibroblasts and immune cells, triggering NF‑κB activation and secretion of pro‑inflammatory cytokines (IL‑1β, TNF‑α, IL‑6)【3】. These cytokines are known to inhibit myogenic differentiation by activating STAT3 and suppressing MyoD expression in satellite cells【4】. In aged TA muscle, satellite cells remain Pax7⁺ and activated (as shown by increased Myf5 expression) but fail to upregulate differentiation markers such as Myogenin and MyHC【2】. We propose that the HA‑TLR4‑NF‑κB axis creates a paracrine barrier that maintains s

Background

The peptide trio BPC‑157, TB‑500 and IGF‑1 is marketed for tendon repair, yet human data are absent and safety concerns linger [1][2]. Preclinical work suggests BPC‑157 up‑regulates growth hormone receptors and nitric oxide pathways [4], TB‑500 modulates actin polymerization to aid cell migration [5], and IGF‑1 drives PI3K‑AKT‑mTORC1 signaling that can stimulate angiogenesis but also poses oncogenic risk [3].

Hypothesis

We propose that a pulsed low‑dose IGF‑1 regimen (e.g., 10 µg/kg administered subcutaneously every 72 h for two weeks) will synergize with standard dosing of BPC‑157 (2.5 mg/kg) and TB‑500 (2.0 mg/kg) to selectively stabilize HIF‑1α in tendon fibroblasts via increased nitric oxide‑mediated PHD inhibition, while avoiding sustained mTORC1 activation because the IGF‑1 pulses are brief enough to let phosphatases reset the pathway. In this state, fibroblasts up‑regulate VEGF‑A and collagen‑III transcription locally, promoting angiogenesis and matrix deposition without systemic proliferative signaling that could fuel tumorigenesis.

Mechanistic Rationale

1. Nitric oxide synergy – BPC‑157 raises iNOS expression, raising NO lev

Hypothesis

In aging, the balance of H3K4me3 and H3K27me3 at bivalent promoters flips relative to cancer, leading to a loss of stem‑like plasticity.

Mechanistic premise

• Cancer maintains a subclass of bivalent promoters (CSBPs) with low H3K27me3/H3K4me3 ratio (LoBiv) that preserves expression of stemness genes such as SOX9 [1, 2].
• This state depends on high H3K4me3 driven by MLL2 recruitment at CpG‑rich promoters and restrained KDM5 activity [4].
• In contrast, aged stem cells show global gain of H3K27me3 and loss of H3K4me3 at loci governing quiescence exit [5].
• We hypothesize that aging drives the opposite epigenetic shift: increased KDM5 activity and/or decreased KDM6 activity converts LoBiv/CSBP‑like promoters into HiBiv configurations (high H3K27me3/H3K4me3), thereby locking cells into a differentiated, non‑plastic state.

Testable predictions

1. In aged murine muscle or intestinal stem cells, ChIP‑seq will reveal a significant increase in the H3K27me3/H3K4me3 ratio at promoters that are LoBiv in young cancer‑derived CSBPs (e.g., Sox9, Nanog, Oct4) [3].
2. Genetic knockdown of Kdm5b in aged stem cells will reduce H3K27me3 accumulation at these promoters, restoring a LoBiv‑like chromatin signature and improving regenerative capacity after injury.
3. Pharmacological inhibition of Kdm6 (e.g.,

Hypothesis

Combined low‑dose BPC-157 and TB-500 synergistically increase endothelial progenitor cell (EPC) mobilization and angiogenesis through a nitric oxide‑dependent SDF‑1α/CXCR4 axis, outperforming the additive effect of each peptide alone.

Rationale

• BPC-157 elevates local nitric oxide (NO) via interaction with growth hormone receptors and NOS pathways [1], which stabilizes HIF-1α and drives stromal cell secretion of SDF-1α (CXCL12).
• TB-500 binds G-actin, promoting actin polymerization that enhances EPC adhesion, chemotaxis toward SDF-1α, and incorporation into nascent vessels [2].
• When NO-mediated SDF-1α release is primed by BPC-157, TB-500-treated EPCs exhibit heightened CXCR4 responsiveness, leading to amplified vascular network formation beyond simple summation.

Testable Prediction

In a diabetic db/db mouse model of ischemic hind-limb, groups receiving:

1. Vehicle
2. BPC-157 alone (10 µg/kg, s.c., daily)
3. TB-500 alone (2 mg/kg, s.c., every other day)

Hypothesis

Senescent cells actively restrict proliferation of neighboring stem and progenitor cells by consuming glutamine and using it to acetylate ARID‑containing lysine demethylases (KDMs). This epigenetic shift biases the senescence‑associated secretory phenotype (SASP) toward TGF‑β‑ and PDGF‑AA‑rich factors that enforce a microenvironmental block on mTORC1 signaling in adjacent cells. When senescent cells are cleared, the glutamine sink disappears, extracellular glutamine rises, ARID‑KDM acetylation in surviving cells shifts, and the SASP skews toward pro‑inflammatory IL‑6/IL‑8 ligands, lifting the proliferative restraint and potentially unleashing tumorigenesis in damaged tissue.

Mechanistic Rationale

Recent work shows senescent fibroblasts are heterogeneous, with subpopulations secreting either reparative (PDGF‑AA, TGF‑β) or inflammatory (IL‑6, IL‑8) factors depending on metabolic and epigenetic states【4】【5】. Glutamine fuels the acetylation of ARID domains on KDM enzymes, altering histone demethylase activity and transcriptional programs【8】. Senescent cells upregulate glutaminase (GLS) and glutamine transporters (SLC1A5), creating a local glutamine‑depleted niche that limits mTORC1 activity in neighboring cells, thereby suppressing cell‑cycle progression. The resulting SASP, enriched in TGF‑β and PDGF‑AA, reinforces this block through SMAD‑dependent transcription of cyclin‑dependent kinase inhibitors (p21, p16).

When senescent cells are removed with senolytics (e.g., D+Q, fisetin)【2】, glutamine rebounds, leading to hyper‑acetylation of ARID‑KDMs in remaining

Hypothesis

Aging brains become over‑consolidated because epigenetic repression of plasticity genes (via HDAC2 and NRSF/REST) and a shift to L‑type Ca2+‑dependent LTP raise the threshold for synaptic updating, making circuits excessively resistant to surprise. We hypothesize that transient, low‑dose disruption of L‑type Ca2+ channels combined with HDAC2 inhibition will lower the LTP threshold, re‑engage synaptic tagging and capture, and restore flexible memory formation without causing global hyperexcitability.

Mechanistic rationale

1. HDAC2 activity suppresses transcription of BDNF, c‑Fos, and other immediate‑early genes needed for new spine formation ([3]).
2. NRSF/REST further silences neuronal activity‑dependent programs, consolidating existing maps.
3. Aging shifts LTP induction from NMDA‑R to L‑type VGCCs, producing slow afterhyperpolarization that occludes plasticity ([4]).
4. Simultaneous partial blockade of L‑type channels (e.g., with low‑dose nifedipine) and HDAC2 inhibition (e.g., via selective siRNA or small‑molecule inhibitor) should:
   • Reduce the calcium‑dependent brake on LTP,
   • Allow NMDA‑R‑dependent LTP to regain dominance,
   • Permit transcriptional reactivation of plasticity genes,
   • Re‑enable synaptic tagging and capture for novel experiences.

Testable predictions

Hypothesis

Aging is propagated not only by soluble SASP but by immune‑cell exosomes that deliver damaged mitochondrial DNA (mtDNA) and oxidative lipids to distant tissues, where they trigger the cGAS‑STING interferon pathway and lock cells into a senescent state.

Mechanistic Rationale

• Senescent immune cells accumulate mitochondrial dysfunction and release exosomes enriched in oxidized mtDNA, cardiolipin, and specific miRNAs (e.g., miR‑34a) that are known to modulate inflammation [1].
• Extracellular mtDNA is a potent agonist of the cytosolic DNA sensor cGAS; its uptake by stromal or parenchymal cells leads to STING‑dependent type I interferon production, which has been shown to reinforce senescence and tissue fibrosis [2].
• Blocking exosome biogenesis with neutral sphingomyelinase 2 (nSMase2) inhibitors reduces the cargo of oxidized mtDNA without affecting overall immune cell numbers, providing a way to test whether the paracrine signal, rather than the immune cell itself, drives aging [3].
• If the hypothesis is correct, lowering circulating exosomal mtDNA should decrease cGAS‑STING activation in liver, kidney, and brain, lower SASP factor levels, and improve functional readouts (grip strength, treadmill endurance, cognitive performance) in aged mice.

Experimental Plan

1. Animal model – Use 20‑month‑old C57BL/6 mice; treat half with GW4869 (nSMase2 inhibitor) administered in

Aging is associated with a numerical expansion of Paneth cells yet a functional decline marked by elevated Notum secretion that flattens the Wnt3 gradient at the crypt base [1][2]. While mTORC1 hyperactivity in Paneth cells has been implicated in Notum upregulation, the upstream trigger linking age‑altered luminal composition to this pathway remains undefined. We hypothesize that age‑related shifts in the gut microbiota increase circulating secondary bile acids, particularly deoxycholic acid (DCA), which activate the G‑protein‑coupled receptor TGR5 on Paneth cells. TGR5 signaling stimulates mTORC1 activity, leading to transcriptional up‑regulation of Notum and subsequent Wnt ligand disengagement from Lrp5/6 receptors, thereby suppressing β‑catenin stabilization in ISCs. This mechanistic chain explains both the numerical rise (Paneth cells proliferate in response to bile acid–mediated signaling) and the functional collapse (Notum‑driven Wnt antagonism) observed with age.

Testable predictions

1. Aged mice will exhibit higher luminal and serum DCA levels compared with young cohorts, correlating with increased TGR5 expression in Paneth cells.
2. Pharmacological inhibition of TGR5 (e.g., with SBI‑115) or genetic deletion of Tgr5 in Paneth cells will reduce mTORC1 activity (measured by p‑S6K), lower Notum secretion, and restore the Wnt3 gradient without altering Paneth cell numbers.
3. Conversely, exogenous DCA administration to young mice will recapitulate the aged phenotype: increased Paneth cell Notum, flattened Wnt gradient, and impaired organoid formation, reversible by

Hypothesis

Elastin fragmentation releases elastin-derived peptides (EDPs) that act as endogenous danger‑associated molecular patterns (DAMPs). These EDPs bind Toll‑like receptor 2 (TLR2) on vascular smooth muscle cells (VSMCs), triggering MyD88‑dependent NF‑κB activation. NF‑κB cooperates with TNFα‑induced Msx2‑Wnt signaling to amplify β‑catenin nuclear translocation, which directly up‑regulates Runx2 and drives osteogenic transdifferentiation. In this model, the immune system does not merely respond to arterial aging; neutrophil‑derived elastase and monocyte‑derived TNFα cooperate to generate EDPs that lock VSMCs into a bone‑like state.

Testable Predictions

1. Pharmacologic blockade of elastase in aged mice will reduce arterial EDP levels, lower VSMC TLR2 signaling, and decrease Runx2 expression without changing total elastin content.
2. Genetic deletion of TLR2 specifically in VSMCs will blunt TNFα‑induced osteogenic programs, preserving contractile markers (SM22α, SMα‑actin) despite ongoing inflammation.
3. Administration of synthetic EDPs to young mice will recapitulate arterial stiffness and VSMC osteogenic changes, an effect abolished by TLR2 antagonism or MyD88 deficiency.
4. Combined inhibition of elastase and TLR2 will produce additive reductions in pulse wave velocity compared with either intervention alone, indicating synergistic immune‑mediated calcification.

Experimental Approach

• Use aged (24‑month) wild‑type and elastase‑deficient (neutrophil‑specific elastase knockout) mice; treat subsets with a selective TLR2 antagonist (e.g.,

Hypothesis

Aging reduces the abundance of IPA‑producing Clostridium sporogenes in the gut, lowering luminal IPA concentrations below the threshold needed to activate intestinal epithelial PXR. This loss of PXR signaling diminishes tight‑junction protein expression and mucus secretion, compromising barrier integrity and allowing increased bacterial translocation. The resulting endotoxemia fuels systemic low‑grade inflammation (inflammaging), which further suppresses C. sporogenes growth, creating a vicious cycle.

Mechanistic Insight

Beyond its canonical role in upregulating occludin, claudin‑1 and ZO‑1, epithelial PXR activation by IPA induces intestinal alkaline phosphatase (IAP) and Nrf2‑dependent antioxidant genes. IAP dephosphorylates LPS, reducing its potency, while Nrf2 limits mitochondrial ROS that otherwise disrupt junctional complexes. In aged epithelium, blunted PXR activity therefore fails to engage these protective pathways, amplifying both barrier leakiness and oxidative stress.

Testable Predictions

1. Microbial rescue – Aged germ‑free mice colonized with a defined C. sporogenes strain will exhibit luminal IPA concentrations of 30‑50 µM, restore epithelial PXR target gene expression (IAP, Nrf2 targets) and increase transepithelial resistance by ≥60 % compared with age‑matched controls receiving vehicle.
2. Epithelial PXR dependence – Intestinal epithelium‑specific PXR knockout (Vil‑Cre;Nr1i2^fl/fl) aged mice colonized with C. sporogenes will show no improvement in barrier metrics or IAP/Nrf2 activation despite normal luminal IPA levels

Hypothesis

Emodin directly inhibits cyclin‑dependent kinase 2 (CDK2) activity, which lowers the phosphorylation of retinoblastoma protein (RB) and shifts the Bax/Bcl‑2 ratio toward apoptosis in senescent cells that rely on TNF-α/NF-κB survival signaling. This CDK2 inhibition converts emodin’s anti‑inflammatory SASP suppression into a senolytic effect.

Rationale

• Emodin binds TNF-α and blocks TNF-α‑TNFR1 interaction, reducing NF-κB driven transcription of IL-6, IL-1β and COX-2 [1].
• Senescent cells often exhibit a senescence-associated secretory phenotype (SASP) that autocrinally activates TNF-α/NF-κB to up-regulate anti-apoptotic BCL-2 family members (e.g., Bcl-2, Bcl-xL) and CDK2 activity, fostering resistance to apoptosis.
• In cancer contexts, emodin shifts Bax↑/Bcl-2↓ and activates caspase-3 without directly inhibiting EGFR kinase [4].
• CDK2 inhibition is known to de-phosphorylate RB, leading to E2F release and transcription of pro-apoptotic genes such as Bax and Puma in stressed cells.
• No study to date has examined emodin’s effect on CDK2 in any cell type, leaving this mechanism unexplored.

Predictions

1. In vitro, emodin will reduce CDK2 kinase activity in a dose-dependent manner, measured by immunoblot for phospho-RB (Ser807/811) and a CDK2 activity assay.
2. Senescent human fibroblasts (induced by irradiation or oncogenic RAS) treated with emodin will show increased Bax/Bcl-2 ratio, cleaved caspase-3, and SA-β-gal loss compared with non-senescent controls.
3. The senolytic effect will be abrogated by overexpressing a kinase-dead CDK2 mutant resistant

Hypothesis

Circadian misalignment of hepatic hepcidin and bone marrow ferroportin rhythms limits iron availability for erythroid progenitors during their DNA synthesis peak, driving anemia in aging. Restoring this iron‑flux rhythm by administering iron supplements at the circadian phase when ferroportin is maximal (subjective night) will normalize heme synthesis, reduce ineffective erythropoiesis, and improve hemoglobin levels in aged mice.

Mechanistic Basis

Erythroid progenitors exhibit a 24‑hour rhythm in DNA synthesis that peaks during the daytime (ZT4‑ZT8) [1]. Iron incorporation into heme must coincide with this S‑phase window; otherwise, excess labile iron fuels ROS generation and apoptosis. Hepcidin, the master iron regulator, is secreted by hepatocytes and displays a circadian oscillation that is antiphasic to ferroportin expression on marrow macrophages and endothelial cells [7]. In aged mice, loss of BMAL1 in endothelial cells flattens these rhythms, causing persistent high hepcidin and low ferroportin, which traps iron in stores and starves erythroblasts when they are primed for proliferation [5].

We propose that the aged niche retains a latent capacity for rhythmic ferroportin transcription that can be re‑entrained by an external iron cue delivered at the appropriate circadian time. By providing iron (e.g., ferrous sulfate) when ferroportin transcription is naturally rising (subjective night, ZT12‑ZT16), we increase extracellular iron export precisely when erythroid progenitors are entering their next DNA synthesis cycle, thereby coupling iron supply w

Hypothesis

Age‑related decline in ileal apical sodium‑dependent bile acid transporter (ASBT/SLC10A2) function is not a passive consequence of reduced enterocyte turnover but is actively driven by the senescence‑associated secretory phenotype (SASP) that suppresses ASBT transcription via NF‑κB signaling, an effect amplified by age‑linked taurine scarcity that shifts the bile acid pool toward glycine‑conjugated species with lower ASBT affinity.

Mechanistic Rationale

1. SASP‑mediated transcriptional repression – Cellular senescence in the intestinal epithelium increases secretion of IL‑6, IL‑1β, and TNF‑α, which activate NF‑κB in neighboring enterocytes. NF‑κB binding to the ASBT promoter has been shown to repress transcription in inflammatory bowel disease models (4). We predict that analogous NF‑κB activation occurs during inflammaging, directly lowering ASBT mRNA and protein levels.
2. Taurine dependence of ASBT kinetics – ASBT transports taurine‑conjugated bile acids (T‑BAs) with higher Vmax than glycine‑conjugated BAs (6). Age‑related decline in circulating taurine (5) reduces the proportion of T‑BAs in the enterohepatic pool, forcing reliance on slower glycine‑BA transport and further decreasing net bile acid reabsorption.
3. Feedback onto hepatic synthesis – Reduced ileal BA uptake diminishes FGF15/19 secretion, lifting hepatic FXR‑mediated repression of CYP7A1 a

Hypothesis

Circadian‑timed intermittent rapamycin dosing restores the proteostatic advantage of caloric restriction by rescuing BMAL1‑gated mTOR oscillation and reducing maladaptive protein half‑life extension.

Mechanistic rationale

Caloric restriction (CR) suppresses mTOR in a circadian‑dependent manner, peaking during the active phase when BMAL1 drives expression of downstream catabolic programs [2]. This temporal gating creates oscillatory windows of mTOR activity that allow transient bursts of protein synthesis necessary for quality control, while extended low‑mTOR periods engage autophagy and reduce oxidative damage [1]. Rapamycin, when given continuously, flattens this oscillation, leading to constitutively low mTOR signaling. Although this reduces translation initiation, it also abolishes the synthetic bursts that replenish short‑lived, damage‑prone proteins, causing a net increase in protein half‑life without a corresponding rise in degradation [1]. The result is a proteome that is longer‑lived but enriched in aged, oxidized species, explaining why CR females retain superior muscle quality despite lower mass [5].

By delivering rapamycin in short pulses aligned with the BMAL1‑driven trough of mTOR activity (e.g., early night in mice), we predict that the drug will mimic CR’s natural oscillation: each pulse suppresses mTOR just enough to activate autophagy and lower oxidative stress, while the intervening trough permits a physiological surge in translation that restores protein turnover. This should lower the average protein half‑life toward CR levels, impro

Hypothesis

Declining luminal indole‑3‑propionic acid (IPA) reduces pregnane X receptor (PXR) activity in aged intestinal epithelium, which reprograms the selective autophagy receptor hierarchy (p62/SQSTM1, NBR1, OPTN, NDP52) to favor degradation of tight‑junction proteins over damaged mitochondria. This shift converts autophagy from a protective housekeeping process into a maladaptive cannibalism ritual that drives barrier leak.

Mechanistic Rationale

PXR is known to bind xenobiotic response elements and drive transcription of barrier genes (ZO‑1, occludin, claudin‑1) [3]. Preliminary chromatin data show PXR motifs enriched near the promoters of SQSTM1 and NBR1, suggesting direct transcriptional control of autophagy receptors. When IPA‑PXR signaling wanes, receptor expression falls unevenly: p62, which has high affinity for ubiquitinated tight‑junction components, declines less than NDP52, which preferentially targets mitochondria. The resulting hierarchy tilt means that, under stress, autophagosomes engulf junctional complexes while sparing malfunctioning mitochondria, amplifying ROS and further weakening the epithelium.

Experimental Design

1. Model – Young (3 mo) and aged (24 mo) C57BL/6 mice; treat aged cohorts with oral IPA (10 mg/kg/day) or vehicle for 4 weeks.
2. Readouts –
   • qPCR and Western blot for PXR target genes (CYP3A11, MDR1) and autophagy receptors (p62, NBR1, OPTN, NDP52) in isolated colonic epithelia.
   • ChIP‑qPCR for PXR binding at SQSTM1 and NBR1 promoters.
   • Autophagy flux assays using bafilomycin A1 to block lysosomal degradati

Hypothesis

Intermittent fasting combined with NMN supplementation increases SIRT1 enzymatic activity in human skeletal muscle more than either intervention alone.

Rationale

NMN and NR reliably double circulating NAD+ levels after two weeks[1], yet no study has shown that this rise translates into SIRT1 activation in human tissues[1]. Fasting elevates NAMPT expression, boosting the NAD+ salvage pathway and promoting fat browning and glucose homeostasis in liver[3]. In mice, time‑restricted feeding plus NMN raises muscle NAD+/NADH ratios beyond each treatment singly, improving mitochondrial function and exercise capacity[2]. These data suggest that fasting may shift NAD+ toward nuclear compartments where SIRT1 resides, while NMN supplies the precursor. Together they could overcome the NAD+‑availability bottleneck that limits SIRT1 firing.

Predictions

1. Participants receiving NMN plus intermittent fasting will exhibit a greater increase in muscle NAD+/NADH ratio than those receiving NMN alone or fasting alone.
2. Elevated NAD+/NADH will correlate with higher SIRT1 activity, measured by decreased acetylation of known substrates such as PGC‑1α and FOXO3a in muscle biopsies.
3. Functional readouts—mitochondrial respiration (via high‑resolution respirometry) and insulin‑stimulated glucose uptake—will improve only in the combined group.

Experimental design

A randomized, crossover trial with three 4‑week arms separated by 4‑week washouts: (A) NMN 250 mg daily, (B) intermittent fasting (16:8 schedule), (C) NMN + intermittent fasting. Primary outcomes: muscle NAD+/NADH

Hypothesis\n\nIn aged liver, senescent hepatic stellate cells (HSCs) establish a spatially restricted IFNγ‑responsive niche that reprograms neighboring Kupffer cells toward an antigen‑presenting, pro‑fibrotic phenotype via JAK‑STAT‑MHC I signaling. This gradient amplifies collagen deposition and sustains a maladaptive wound‑healing loop.\n\n## Rationale\n\n- Spatial transcriptomics of aged brain (GSE212903) and lung reveals quantitative expression gradients around senescent cells, showing upregulated IFNγ receptors and SASP factors with membrane localization shifts [1].\n- In idiopathic pulmonary fibrosis, cell2location deconvolution of Visium data links senescence scores to basaloid epithelial niches and fibrosis pathways, demonstrating that spatial ligand‑receptor analysis can uncover rewired IFNγ sensing [2].\n- Human Alzheimer’s data (GSE263468) show that resilient neuronal subsets retain layer‑specific programs despite pathology, highlighting how spatial deconvolution isolates vulnerable versus protected compartments [3].\n\nThese studies establish a paradigm: senescent cells sculpt membranous IFNγ signaling hotspots that alter neighboring cell states. Yet we haven't mapped this mechanism in liver, where HSC‑driven senescence is a known driver of age‑related fibrosis.\n\n## Novel Mechanistic Insight\n\nWe propose that senescent HSCs release exosomes enriched in miR‑21 and TGF‑β1, which deliver cargo to Kupffer cell surfaces, promoting endocytosis and clustering of IFNγ receptors. It's this receptor clustering that enhances JAK1/STAT1 phosphorylation while concurrent

Hypothesis

Selective inhibition of the NLRP3 inflammasome in thymic stromal cells maintains protective IL‑6 classical signaling while preventing pathological trans‑signaling, thereby preserving naïve T cell production in aged individuals.

Rationale

• NLRP3 activation raises intrathymic IL‑1β, driving thymic involution and reducing thymic output 1.
• NLRP3 deficiency in aged mice improves T cell reconstitution after HSCT and increases naïve T cell numbers 1.
• Aged macrophages produce less IL‑6, yet IL‑6 can act both as a suppressor of inflammation and as a driver of STAT3‑mediated chronic inflammation via trans‑signaling 2, 3.
• Tocilizumab (IL‑6R blockade) and siltuximab (IL‑6 ligand neutralization) have distinct effects on Tfh, Treg and STAT3 signaling, indicating that classical versus trans‑signaling pathways diverge in function 4.

Mechanistic Insight

We propose that NLRP3 inflammasome activity in thymic epithelial cells (TECs) induces a local shift from membrane‑bound IL‑6R (classical signaling) to increased shedding of soluble IL‑6R (sIL‑6R). The rise in sIL‑6R enables IL‑6 trans‑signaling, which activates STAT3 in nearby thymocytes, promoting apoptosis and skewing differentiation toward inflammatory phenotypes. Simultaneously, NLRP3‑driven IL‑1β amplifies NF